• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猫口腔鳞状细胞癌中上皮-间充质转化的免疫组织化学特征。

Immunohistochemical Features of Epithelial-Mesenchymal Transition in Feline Oral Squamous Cell Carcinoma.

机构信息

College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.

College of Veterinary Medicine, Michigan State University, East Lansing, MI, USA.

出版信息

Vet Pathol. 2019 Nov;56(6):826-839. doi: 10.1177/0300985819859873. Epub 2019 Jul 22.

DOI:10.1177/0300985819859873
PMID:31331247
Abstract

Feline oral squamous cell carcinoma (FOSCC) is an aggressive malignancy with invasive and metastatic behavior. It is poorly responsive to chemotherapy and radiation. Neoplastic epithelial-mesenchymal transition (EMT) portends highly malignant behavior and enhances resistance to therapy. In transitioning to a more malignant phenotype, carcinoma stem cells undergo transformation mediated by expression of proteins, endowing them with mesenchymal properties advantageous to cell survival. The goal of the current study was to identify proteins associated with EMT in FOSCC. This study documents protein expression patterns in 10 FOSCC biopsies and 3 FOSCC cell lines (SCCF1, SCCF2, SCCF3), compatible with an EMT phenotype. As markers of EMT, P-cadherin, N-cadherin, vimentin, nuclear transcription factors Twist and Snail, hypoxia inducible factor 1α (HIF-1α), programmed death ligand 1, and vascular endothelial growth factor D, as well as E-cadherin, were examined using immunohistochemistry, Western blot, and enzyme-linked immunosorbent assay. P-cadherin, Twist, HIF-1α, and programmed death ligand 1 were commonly expressed in biopsies and cell lines. N-cadherin, classically associated with EMT, was not highly expressed, and E-cadherin was coexpressed along with proteins characteristic of EMT in all specimens. Production of vascular endothelial growth factor A by cell lines, a process regulated by HIF-1α expression, was suppressed by the small-molecule inhibitor dasatinib. These data are consistent with EMT in FOSCC and shed light on cellular changes that could contribute to the aggressive behavior of FOSCC.

摘要

猫口腔鳞状细胞癌 (FOSCC) 是一种具有侵袭性和转移性的侵袭性恶性肿瘤。它对化疗和放疗反应不佳。肿瘤上皮间质转化 (EMT) 预示着高度恶性行为,并增强了对治疗的抵抗力。在向更恶性的表型转变过程中,癌干细胞通过表达蛋白质发生转化,赋予它们有利于细胞存活的间质特性。目前研究的目的是鉴定与 FOSCC 中的 EMT 相关的蛋白质。这项研究记录了 10 例 FOSCC 活检和 3 种 FOSCC 细胞系 (SCCF1、SCCF2、SCCF3) 中的蛋白质表达模式,这些细胞系与 EMT 表型一致。作为 EMT 的标志物,使用免疫组织化学、Western blot 和酶联免疫吸附试验检查了 P-钙黏蛋白、N-钙黏蛋白、波形蛋白、核转录因子 Twist 和 Snail、缺氧诱导因子 1α (HIF-1α)、程序性死亡配体 1 和血管内皮生长因子 D 以及 E-钙黏蛋白的表达。P-钙黏蛋白、Twist、HIF-1α 和程序性死亡配体 1 在活检和细胞系中普遍表达。N-钙黏蛋白与 EMT 经典相关,但表达不高,E-钙黏蛋白与所有标本中 EMT 特征蛋白共同表达。由 HIF-1α 表达调节的血管内皮生长因子 A 的产生由细胞系产生,小分子抑制剂 dasatinib 抑制该过程。这些数据与 FOSCC 中的 EMT 一致,并阐明了可能导致 FOSCC 侵袭性行为的细胞变化。

相似文献

1
Immunohistochemical Features of Epithelial-Mesenchymal Transition in Feline Oral Squamous Cell Carcinoma.猫口腔鳞状细胞癌中上皮-间充质转化的免疫组织化学特征。
Vet Pathol. 2019 Nov;56(6):826-839. doi: 10.1177/0300985819859873. Epub 2019 Jul 22.
2
Monoclonal antibody cetuximab impairs matrix metalloproteinases 2 and 9, epithelial-mesenchymal transition and cell migration in feline oral squamous cell carcinoma in vitro.单克隆抗体西妥昔单抗在体外可抑制猫口腔鳞状细胞癌中的基质金属蛋白酶2和9、上皮-间质转化及细胞迁移。
Vet Comp Oncol. 2024 Mar;22(1):149-155. doi: 10.1111/vco.12943. Epub 2023 Nov 29.
3
Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.犬口腔和皮肤鳞状细胞癌的浸润前沿分级及上皮-间质转化
Vet Pathol. 2017 Sep;54(5):783-791. doi: 10.1177/0300985817707005. Epub 2017 May 11.
4
Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.牛乳铁蛋白可逆转口腔鳞状细胞癌中上皮-间充质转化的编程为间充质-上皮转化。
Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):142-147. doi: 10.1016/j.bbrc.2018.10.193. Epub 2018 Nov 8.
5
Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.上皮间质转化标志物与原发性皮肤鳞状细胞癌的转移风险增加相关,但在淋巴结转移中减弱。
J Dermatol Sci. 2013 Nov;72(2):93-102. doi: 10.1016/j.jdermsci.2013.07.001. Epub 2013 Jul 15.
6
Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.咖啡酸和二甲双胍通过作用于不同的分子靶点抑制 TGF-β1 诱导的 C-4I 和 HTB-35/SiHa 人宫颈鳞癌细胞侵袭表型。
Int J Mol Sci. 2018 Jan 16;19(1):266. doi: 10.3390/ijms19010266.
7
Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.骨形态发生蛋白-4 通过上皮-间充质转化诱导口腔鳞状细胞癌细胞系中干细胞表型的显现。
Oncol Rep. 2011 Aug;26(2):455-61. doi: 10.3892/or.2011.1299. Epub 2011 May 10.
8
The role of epithelial-mesenchymal transition in squamous cell carcinoma of the oral cavity.上皮-间质转化在口腔鳞状细胞癌中的作用。
Virchows Arch. 2018 Feb;472(2):237-245. doi: 10.1007/s00428-017-2192-1. Epub 2017 Jul 12.
9
Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis.缺氧诱导因子1α诱导的子宫内膜上皮细胞上皮-间质转化可能促进子宫内膜异位症的发生发展。
Hum Reprod. 2016 Jun;31(6):1327-38. doi: 10.1093/humrep/dew081. Epub 2016 Apr 19.
10
HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.缺氧诱导因子-1α通过Snail信号通路诱导胃癌干细胞发生上皮-间质转化。
Oncotarget. 2017 Feb 7;8(6):9535-9545. doi: 10.18632/oncotarget.14484.

引用本文的文献

1
In vitro expression of genes encoding HIF1α, VEGFA, PGE2 synthases, and PGE2 receptors in feline oral squamous cell carcinoma.猫口腔鳞状细胞癌中编码缺氧诱导因子1α、血管内皮生长因子A、前列腺素E2合成酶和前列腺素E2受体的基因的体外表达
J Vet Diagn Invest. 2025 Mar;37(2):223-233. doi: 10.1177/10406387251315677. Epub 2025 Feb 10.
2
A radiobiological perspective on radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma.头颈部鳞状细胞癌放射抗性或/和放射敏感性的放射生物学视角。
Rep Pract Oncol Radiother. 2024 Feb 16;28(6):809-822. doi: 10.5603/rpor.99355. eCollection 2023.
3
Histologic, immunohistochemical, and in situ hybridization study of myxoid stroma in feline oral squamous cell carcinoma.
猫口腔鳞状细胞癌黏液样基质的组织学、免疫组织化学和原位杂交研究
J Vet Med Sci. 2024 Mar 1;86(3):258-265. doi: 10.1292/jvms.23-0356. Epub 2024 Jan 18.
4
Feline SCCs of the Head and Neck Display Partial Epithelial-Mesenchymal Transition and Harbor Stem Cell-like Cancer Cells.猫头部和颈部的鳞状细胞癌表现出部分上皮-间质转化并含有干细胞样癌细胞。
Pathogens. 2023 Oct 27;12(11):1288. doi: 10.3390/pathogens12111288.
5
Radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma: biological angle.头颈部鳞状细胞癌的放射抵抗和/或放射敏感:生物学角度。
Oral Maxillofac Surg. 2024 Jun;28(2):547-555. doi: 10.1007/s10006-023-01189-9. Epub 2023 Nov 8.
6
Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma.猫口腔鳞状细胞癌的基因组格局和基因表达谱
Front Vet Sci. 2023 May 17;10:1079019. doi: 10.3389/fvets.2023.1079019. eCollection 2023.
7
Anti-EGFR monoclonal antibody Cetuximab displays potential anti-cancer activities in feline oral squamous cell carcinoma cell lines.抗表皮生长因子受体(EGFR)单克隆抗体西妥昔单抗在猫口腔鳞状细胞癌细胞系中显示出潜在的抗癌活性。
Front Vet Sci. 2022 Nov 17;9:1040552. doi: 10.3389/fvets.2022.1040552. eCollection 2022.
8
Vasohibin 2 promotes lymphangiogenesis of lung squamous cell carcinoma through snail-dependent vascular endothelial growth factor-D (VEGF-D) signaling pathway.血管抑制素2通过依赖蜗牛蛋白的血管内皮生长因子-D(VEGF-D)信号通路促进肺鳞状细胞癌的淋巴管生成。
Ann Transl Med. 2022 Jan;10(2):39. doi: 10.21037/atm-21-4865.
9
Identification of the interleukin-8 (CXCL-8) pathway in feline oral squamous cell carcinoma - A pilot study.鉴定猫口腔鳞状细胞癌中的白细胞介素-8(CXCL-8)通路 - 一项初步研究。
Can J Vet Res. 2022 Jan;86(1):13-19.
10
Immunocytochemical evaluation of epithelial-mesenchymal transition in epithelial tumors of dogs and cats.免疫细胞化学评价犬猫上皮性肿瘤的上皮-间充质转化。
J Vet Med Sci. 2021 Sep 3;83(9):1363-1368. doi: 10.1292/jvms.21-0021. Epub 2021 Jul 8.